Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Austin Lee Resourcing

    Austin Lee Resourcing was founded with a clear sense of purpose to provide a high level service that is efficient, genuine and innovative to both our candidates and our clients. Our objective is to provide informed career advice and opportunities to our candidates and added value to our clients’ global resourcing needs. Our combined expertise in Business Operations, Finance, Healthcare plus Communications helps us deliver this.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    - PMLiVE

    M3 (EU)

    M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

    View Profile

    Digital communications, Medical education, Recruitment and career development

    Company Details

    Austin Lee Resourcing
    North West London, London, N3, United Kingdom
    0208 371 5603
    Contact Austin Lee Resourcing
    Website

     Latest Content from PMHub 

    Case Study: Private market opportunity for a travel vaccine

    White Papers and Resources | August 12, 2016 | Inizio

    Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. It was crucial to determine:Which markets had the highest potential to...

    Infographic: Conference Live

    White Papers and Resources | August 12, 2016 | Inizio

    Conference Live gives you real-time insights, utilising the multimedia functionality of the smartphone in an innovative mobile app methodology. We conduct mobile conference research amongst physicians attending conferences, giving our clients...

    Blog: The Cost of Counterfeits

    White Papers and Resources | August 12, 2016 | Inizio

    The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.

    Video: Self-pay and Emerging Markets

    White Papers and Resources | August 12, 2016 | Inizio

    A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public...

    News: Therapy Watch HCV expands into 4 additional EU markets

    White Papers and Resources | August 12, 2016 | Inizio

    The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment of HCV has moved on in a short space...

    News: Research Partnership launches new patient report – Living with Ulcerative Colitis

    White Papers and Resources | August 12, 2016 | Inizio

    Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain...

    Summer Intern experience at Research Partnership

    White Papers and Resources | August 12, 2016 | Inizio

    We look for bright and inquisitive people who want to learn in a company that's pushing the boundaries of pharmaceutical market research

    Health Unlimited announces partnership with HealthUnlocked to expand direct-to-consumer insight and engagement

    Press Releases | August 12, 2016 | Health Unlimited

    London, 12th August 2016. Health Unlimited, the specialist healthcare marketing communications group, part of Creston Unlimited, today announces a global partnership agreement with HealthUnlocked.

    What kind of customer data are you getting?

    White Papers and Resources | August 10, 2016 | Anthill Agency

    How to collect the proper data to discover how to act next.

    Products as portfolios: positioning immuno-oncology products

    White Papers and Resources | August 9, 2016 | Blue Latitude Health

    The last few years have seen a huge proliferation in the number of products entering the oncology space, with a lot more currently being investigated in clinical trials. Effective positioning...